[HTML][HTML] Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods

KM Lisdahl, KJ Sher, KP Conway, R Gonzalez… - Developmental cognitive …, 2018 - Elsevier
One of the objectives of the Adolescent Brain Cognitive Development (ABCD) Study
(https://abcdstudy. org/) is to establish a national longitudinal cohort of 9 and 10 year olds …

Does inhibitory control training improve health behaviour? A meta-analysis

V Allom, B Mullan, M Hagger - Health psychology review, 2016 - Taylor & Francis
Objectives: Inhibitory control training has been hypothesised as a technique that will
improve an individual's ability to overrule impulsive reactions in order to regulate behaviour …

Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized …

MP Bogenschutz, S Ross, S Bhatt, T Baron… - JAMA …, 2022 - jamanetwork.com
Importance Although classic psychedelic medications have shown promise in the treatment
of alcohol use disorder (AUD), the efficacy of psilocybin remains unknown. Objective To …

Alcohol consumption in response to the COVID-19 pandemic in the United States

C Barbosa, AJ Cowell, WN Dowd - Journal of Addiction Medicine, 2021 - journals.lww.com
Objectives: Excessive alcohol use is a serious and growing public health problem. Alcoholic
beverage sales in the United States increased greatly immediately after the stay-at-home …

Long-term follow-up of psilocybin-facilitated smoking cessation

MW Johnson, A Garcia-Romeu… - The American journal of …, 2017 - Taylor & Francis
Background: A recent open-label pilot study (N= 15) found that two to three moderate to high
doses (20 and 30 mg/70 kg) of the serotonin 2A receptor agonist, psilocybin, in combination …

Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial

TP Freeman, C Hindocha, G Baio… - The Lancet …, 2020 - thelancet.com
Background A substantial and unmet clinical need exists for pharmacological treatment of
cannabis use disorders. Cannabidiol could offer a novel treatment, but it is unclear which …

Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study

MP Bogenschutz, AA Forcehimes… - Journal of …, 2015 - journals.sagepub.com
Several lines of evidence suggest that classic (5HT2A agonist) hallucinogens have clinically
relevant effects in alcohol and drug addiction. Although recent studies have investigated the …

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

MW Johnson, A Garcia-Romeu… - Journal of …, 2014 - journals.sagepub.com
Despite suggestive early findings on the therapeutic use of hallucinogens in the treatment of
substance use disorders, rigorous follow-up has not been conducted. To determine the …

LGB-affirmative cognitive-behavioral therapy for young adult gay and bisexual men: A randomized controlled trial of a transdiagnostic minority stress approach.

JE Pachankis, ML Hatzenbuehler… - Journal of consulting …, 2015 - psycnet.apa.org
Objectives: We tested the preliminary efficacy of a transdiagnostic cognitive-behavioral
treatment adapted to improve depression, anxiety, and co-occurring health risks (ie, alcohol …

[HTML][HTML] A mind-brain-body dataset of MRI, EEG, cognition, emotion, and peripheral physiology in young and old adults

A Babayan, M Erbey, D Kumral, JD Reinelt, AMF Reiter… - Scientific data, 2019 - nature.com
We present a publicly available dataset of 227 healthy participants comprising a young (N=
153, 25.1±3.1 years, range 20–35 years, 45 female) and an elderly group (N= 74, 67.6±4.7 …